ScrutarSign up free

DME Capital Management (David Einhorn)

Famous investors

Files as DME Capital Management, LP (formerly Greenlight Capital) (SEC CIK 1489933). Portfolio from its latest quarterly 13F-HR filing.

$3.91B
Tracked value
46
Positions
Q2 2026
Portfolio as of
Aug 14, 2026
Filed

Holdings

#CompanyPortfolio %vs Q1 2026Value
1GRBKGreen Brick Partners, Inc.19.4%unch.$757.77M
2FLRFLUOR CORP6.2%▼ 1.9%$244.07M
3CNRCore Natural Resources, Inc.4.7%▲ 22.9%$182.7M
4BHFBrighthouse Financial, Inc.4.6%unch.$179.9M
5ACHCAcadia Healthcare Company, Inc.3.3%▼ 2.6%$129.95M
6PENNPENN Entertainment, Inc.3.2%▼ 3.0%$125.18M
7FBINFortune Brands Innovations, Inc.3.1%NEW$123.08M
8PCGPG&E Corp2.9%unch.$111.56M
9CNCCENTENE CORP2.7%▼ 39.6%$105.99M
10GPKGRAPHIC PACKAGING HOLDING CO2.7%▲ 9.4%$105.21M
11SNXTD SYNNEX CORP2.6%▼ 20.5%$101.87M
12TEVATEVA PHARMACEUTICAL INDUSTRIES LTD2.5%▼ 0.8%$97.78M
13VGNTVersigent PLC2.4%NEW$95.68M
14CPRICapri Holdings Ltd2.3%▼ 2.2%$89.51M
15BKVBKV Corp2.2%▲ 14.8%$84.68M
16DHTDHT Holdings, Inc.2.1%▼ 4.5%$83.22M
17CROXCrocs, Inc.2.1%unch.$80.73M
18ROIVRoivant Sciences Ltd.1.9%unch.$76.18M
19SHCSotera Health Co1.9%▲ 100%$73.41M
20VSNTVersant Media Group, Inc.1.8%▼ 36.5%$69.22M
21PRMBPrimo Brands Corp1.8%NEW$69.01M
22DCHDauch Corp1.7%▲ 96.4%$67.18M
23PYPLPayPal Holdings, Inc.1.6%NEW$61.5M
24HSICHENRY SCHEIN INC1.5%▲ 19.9%$60.01M
25WBDWarner Bros. Discovery, Inc.1.5%NEW$59.88M
26LBTYALiberty Global Ltd.1.4%unch.$56.43M
27ARANTERO RESOURCES Corp1.4%▲ 94.7%$55.32M
28STUBStubHub Holdings, Inc.1.4%unch.$54.48M
29REZIRESIDEO TECHNOLOGIES, INC.1.4%▲ 7.9%$52.86M
30DECKDECKERS OUTDOOR CORP1.3%▲ 5.2%$50.28M
31SPBSpectrum Brands Holdings, Inc.1.2%▼ 13.7%$48.14M
32CNHCNH Industrial N.V.1.2%unch.$47.04M
33VTRSViatris Inc1.1%▲ 52.6%$44.04M
34SKYDSkydance Corp1.0%unch.$38.71M
35PVHPVH CORP. /DE/1.0%NEW$38.67M
36CMCSACOMCAST CORP0.8%NEW$33.04M
37SLDESlide Insurance Holdings, Inc.0.8%unch.$32.67M
38TRIPTripAdvisor, Inc.0.8%▲ 51.0%$32.38M
39GLDSPDR GOLD TRUST0.8%▼ 16.3%$30.73M
40CICigna Group0.6%unch.$24.37M
41LKFTLakefront Biotherapeutics NV0.4%unch.$14.47M
42COYACoya Therapeutics, Inc.0.3%unch.$13.66M
43IMVTImmunovant, Inc.0.1%unch.$3.6M
44GPROGoPro, Inc.0.0%unch.$1.32M
45GANXGain Therapeutics, Inc.0.0%unch.$1.15M
46NUVBNuvation Bio Inc.0.0%unch.$198.8K

Positions in companies on Scrutar, from the manager's latest quarterly 13F-HR filing. 13F filings disclose US-listed long positions only and can be filed up to 45 days after quarter end, so the portfolio may have changed since. Portfolio % is each position's share of the tracked value shown above. Changes compare share counts against the Q1 2026 filing, adjusted for stock splits.

Never miss a DME Capital Management (David Einhorn) 13F.

Get an email when DME Capital Management (David Einhorn) files its next quarterly 13F with the SEC, including the portfolio's notable changes. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Source: SEC EDGAR Form 13F-HR filings.